Inicio › Obesidad › Florida › Orlando
Ensayos clínicos de Obesidad en Orlando, FL
31 estudios para Obesidad buscan participantes en centros de Orlando y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
ReclutandoFase 2
- Charter Research - Winter Park /ID# 281968, Orlando
- Florida Institute For Clinical Research /ID# 282739, Orlando
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Reclutando
- Orlando Health, Inc., Orlando
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
ReclutandoFase 1Se aceptan voluntarios sanos
- Kailera Clinical Site, Orlando
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
ReclutandoFase 2
- Florida Institute For Clinical Research, LLC, Orlando
- K2 Medical Research - Maitland, Maitland · A 6 mi de distancia
- Omega Research Orlando, Altamonte Springs · A 9 mi de distancia
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
ReclutandoFase 3
- Florida Institute for Clinical Research, LLC, Orlando
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
ReclutandoFase 2
- Clinical Site Partners, LLC DBA Flourish Research, Winter Park · A 5 mi de distancia
- K2 Medical Research Maitland LLC, Main Office, Maitland · A 6 mi de distancia
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
ReclutandoFase 2
- Clinical Neuroscience Solutions, Orlando
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
ReclutandoFase 3
- Clinical Neuroscience Solution, Orlando
- Florida Institute for Clinical Research, LLC, Orlando
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
ReclutandoFase 3
- Florida Inst For Clin Res LLC, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
ReclutandoFase 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
ReclutandoFase 3
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
ReclutandoFase 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
ReclutandoFase 3
- Clinical Neuroscience Solution, Orlando
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
ReclutandoFase 3
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · A 5 mi de distancia
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
ReclutandoFase 3
- Research Site, Ocoee · A 10 mi de distancia
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
ReclutandoFase 3
- West Orange Endocrinology, Ocoee · A 10 mi de distancia
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
ReclutandoFase 3
- Conquest Research, Winter Park · A 5 mi de distancia
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
ReclutandoFase 2
- Charter Research - Winter Park, Orlando
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
ReclutandoFase 3
- AURORA-1 Clinical Site, Winter Park · A 5 mi de distancia
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
ReclutandoFase 3
- AURORA-2 Clinical Site, Winter Park · A 5 mi de distancia
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
ReclutandoFase 3
- AdventHealth Orlando, Orlando
- Orlando Health Heart Institute, Orlando
- Guardian Research Organization LLC, Winter Park · A 5 mi de distancia
- y 1 más
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
Reclutando
- University of Central Florida, Orlando
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
ReclutandoFase 3Se aceptan voluntarios sanos
- ACCOMPLISH-2 Research Site, Ocoee · A 10 mi de distancia
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
ReclutandoFase 2
- Charter Research - Winter Park, Orlando
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
ReclutandoFase 3
- Kailera Clinical Site, Orlando
- Kailera Clinical Site, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
ReclutandoFase 3
- Clinical Neuroscience Solutions - Orlando, Orlando
- Combined Research Orlando Phase I IV, Orlando
- Florida Institute for Clinical Research, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
ReclutandoFase 3
- Florida Institute for Clinical Research, Orlando
- Conquest Research - Winter Park, Winter Park · A 5 mi de distancia
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
ReclutandoFase 3
- Clinical Neuroscience Solutions, Orlando
- Florida Institute for Clinical Research, Orlando
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
ReclutandoFase 3
- Cardiovascular Institute of Orlando, Orlando
- Guardian Research Org LLC, Winter Park · A 5 mi de distancia
- K2 Medical Research, Maitland · A 6 mi de distancia
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
ReclutandoFase 3
- ACCOMPLISH-1 Research Site, Ocoee · A 10 mi de distancia
Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise
ReclutandoSe aceptan voluntarios sanos
- AdventHealth Translational Research Institute, Orlando
Más información sobre Obesidad en MedlinePlus
Ensayos de Obesidad en otras ciudades
- Houston, TX43 estudios
- Chicago, IL41 estudios
- New York City, NY40 estudios
- San Antonio, TX40 estudios
- Washington, DC33 estudios
- Dallas, TX30 estudios
- Boston, MA28 estudios
- Las Vegas, NV27 estudios
- Miami, FL27 estudios
- Baltimore, MD25 estudios
- Jacksonville, FL25 estudios
- St. Louis, MO25 estudios
Otros estudios en Orlando
- Cáncer de pulmón de células no pequeñas44 estudios
- Cáncer metastásico29 estudios
- Sobrepeso27 estudios
- Enfermedad de Alzheimer25 estudios
- Diabetes tipo 224 estudios
- Cáncer (todos los tipos)24 estudios
- Cáncer de seno23 estudios
- Cáncer de ovario22 estudios
- Colitis ulcerativa22 estudios
- Cáncer de pulmón21 estudios
- Cáncer del colon y del recto19 estudios
- Trastorno depresivo mayor19 estudios
De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.